| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/05/2004 | WO2004064810A1 Tablet quickly melting in oral cavity |
| 08/05/2004 | WO2004064809A1 Solid pharmaceutical composition comprising ramipril |
| 08/05/2004 | WO2004064808A1 Drug particles obtained by freezing onto a cold surface |
| 08/05/2004 | WO2004064807A1 Sustained-release preparations and method for producing the same |
| 08/05/2004 | WO2004064806A2 Process for modifying drug crystal formation |
| 08/05/2004 | WO2004064805A1 Cochleate preparations of fragile nutrients |
| 08/05/2004 | WO2004064804A1 Povidone-iodine-based ophthalmological preparations |
| 08/05/2004 | WO2004064803A1 Topical pharmaceutical and/or cosmetic dispense systems |
| 08/05/2004 | WO2004064788A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064787A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064786A2 Article for debridement and detoxification of wounds |
| 08/05/2004 | WO2004064779A2 Use of nitroglycerin to relieve nocturnal muscle cramps |
| 08/05/2004 | WO2004064772A2 Methods and dosage forms with modified viscosity layers |
| 08/05/2004 | WO2004064767A2 Nitric oxide inducing agents |
| 08/05/2004 | WO2004064758A2 Improved oral delivery of peptides |
| 08/05/2004 | WO2004064757A2 Absorption enhancing agents |
| 08/05/2004 | WO2004064752A2 Method of preparing sustained release microparticles |
| 08/05/2004 | WO2004064736A2 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/05/2004 | WO2004064735A2 Treatment of benign prostatic hyperplasia |
| 08/05/2004 | WO2004064731A2 Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymlplhoid tissues |
| 08/05/2004 | WO2004064726A2 Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions |
| 08/05/2004 | WO2004064719A2 Synergistic compositions and methods for potentiating anti-oxidative activity |
| 08/05/2004 | WO2004064717A2 Cop 1 for treatment of inflammatory bowel diseases |
| 08/05/2004 | WO2004064708A2 Solution for nostril wash |
| 08/05/2004 | WO2004064667A1 Unit dose delivery system for dental sensitivity product |
| 08/05/2004 | WO2004064543A1 Compositions containing coenzyme q10 |
| 08/05/2004 | WO2004064542A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | WO2004045494A9 Biological glue based on thrombin-conjugated nanoparticles |
| 08/05/2004 | WO2004043513A3 Surface dissolution and/or bulk erosion controlled release compositions and devices |
| 08/05/2004 | WO2004043389A3 Methods of treating cancer and related methods |
| 08/05/2004 | WO2004035762A3 Microencapsulation and sustained release of biologically active polypeptides |
| 08/05/2004 | WO2004032859A3 Water soluble sheet composition |
| 08/05/2004 | WO2004026235A3 Pharmaceutical compositions with improved dissolution |
| 08/05/2004 | WO2004012672A3 Cell transport compositions and uses thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2004001019A3 Novel nanoparticles and use thereof |
| 08/05/2004 | WO2004000226A3 Liposomes containing biologically active compounds |
| 08/05/2004 | WO2003102150A3 Multi-functional polyamines for delivery of biologically-active polynucleotides |
| 08/05/2004 | WO2003084386A3 Methods for ultrasonic imaging and treating diseased tissues |
| 08/05/2004 | WO2003066126A3 Dermal access member |
| 08/05/2004 | WO2003022328A3 Infusion device and driving mechanism for same |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | WO2002064014A3 Endomural therapy |
| 08/05/2004 | US20040153040 Multi-layer synthetic dressing with cooling characteristics |
| 08/05/2004 | US20040153029 Non-constant pressure infusion pump |
| 08/05/2004 | US20040152886 Reacting hydroxypropylmethyl cellulose, alkali acetate, phthalic anhydride and alkali chlorate in acetic acid solvent and recovering granular hydroxypropylmethyl cellulose phthalate; for use in pharmaceuticals, foods and cosmetics |
| 08/05/2004 | US20040152789 Complex of calcium compound and phosphate; adjustment pH |
| 08/05/2004 | US20040152784 Mixture of sodium phenylbutyric acid, flavoring and artificial sweetening |
| 08/05/2004 | US20040152770 Highly-packed polycationic ammonium, sulfonium and phosphonium lipids |
| 08/05/2004 | US20040152752 Administering cyclooxygenase inhibitor; topical administering |
| 08/05/2004 | US20040152720 Powdered medicaments containing a tiotropium salt and salmeterol xinafoate |
| 08/05/2004 | US20040152683 Use of mometasone furoate for treating airway passage and lung diseases |
| 08/05/2004 | US20040152682 Stabilized steroid composition and method for its preparation |
| 08/05/2004 | US20040152672 Indole compounds useful for the treatment of cancer |
| 08/05/2004 | US20040152664 Prednisolone compositions |
| 08/05/2004 | US20040152663 Dissolving an amphiphilic heparin derivative comprising heparin covalently bonded to a hydrophobic agent selected from bile acids, sterols, alkanoic acids, and mixtures thereof in a water phase; dispersing in organic phase; drying emulsion |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152647 For use in gene therapy |
| 08/05/2004 | US20040152622 Closed loop therapy system for controlling a concentration of a substance, such as blood glucose concentration, in the body of a user |
| 08/05/2004 | US20040152612 Use as carrier systems for active ingredients from the ubiquinone class which are slightly soluble in water; suitable for oral administration in the form of unit dose forms |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152112 Compositions and methods for cancer diagnosis and therapy |
| 08/05/2004 | US20040152042 Dispensing apparatus and cartridge with deformable tip |
| 08/05/2004 | US20040151938 Supplying to human or animals; into brain, tissues, lungs; coils, spring |
| 08/05/2004 | US20040151855 Injection-molded water soluble container |
| 08/05/2004 | US20040151793 Onion extract can be integrated into base containing oil without effectiveness being reduced or phase separation being produced |
| 08/05/2004 | US20040151783 Therapeutic compositions |
| 08/05/2004 | US20040151781 Osteoporosis, hormone-related disorders |
| 08/05/2004 | US20040151779 suspending an active agent-containing powder with active agent hydration less than about 10% in at least one anhydrous, aprotic, hydrophobic, non-polar, low-reactivity vehicle; useful to delivery to an animal for sustained release for long term treatment |
| 08/05/2004 | US20040151778 Plant protein-based microcapsules |
| 08/05/2004 | US20040151777 Modified cellulose films |
| 08/05/2004 | US20040151776 Novel compositions |
| 08/05/2004 | US20040151775 Membrane active polymers |
| 08/05/2004 | US20040151774 Therapeutic compositions for drug delivery to and through covering epithelia |
| 08/05/2004 | US20040151773 core containing a complex of the benzimidazole derivative e.g., omeprazole, lansoprazole, pantoprazole, or timoprazole, and ion-exchange resin, and the enteric coating agent having the degree of substitution by an acidic group of less than 30%, |
| 08/05/2004 | US20040151772 Controlled release carvedilol compositions |
| 08/05/2004 | US20040151771 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
| 08/05/2004 | US20040151770 e.g., tiotropium, oxitropium or ipratropium salt and (S)-N-[2-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-2-[4-(2-hydroxy-1-hydroxymethyl-ethylamino)-piperidin-1-yl]-N-methyl-2-phenylacetamide or salt; respiratory diseases |
| 08/05/2004 | US20040151769 Film coated tablet containing an extract of red vine leaves |
| 08/05/2004 | US20040151768 Pharmaceutical compositions containing an effervescent acid-base couple |
| 08/05/2004 | US20040151767 Rapidly expanding starches with altered crystalline structure |
| 08/05/2004 | US20040151763 pH adjuster namely citric acid, preservative, and an anti-irritant agent, especially a local anesthetic, analgesic, anesthetic, antipruitic, astringent, hydrocortisone preparation, or keratolytic; feminine wipe |
| 08/05/2004 | US20040151762 Cough mitt |
| 08/05/2004 | US20040151759 Non-animal product containing veterinary formulations |
| 08/05/2004 | US20040151756 Edible low density high surface area drug vehicle, method of manufacturing low density high surface area drug vehicle |
| 08/05/2004 | US20040151754 Steroid suspensions for intraocular use |
| 08/05/2004 | US20040151753 biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent; sustained release |
| 08/05/2004 | US20040151752 Hydrogel entrapping therapeutic agent and stent with coating comprising this |
| 08/05/2004 | US20040151744 Avermectin and praziquantel combination therapy |
| 08/05/2004 | US20040151743 Antibacterial composition for topical administration containing antibiotic |
| 08/05/2004 | US20040151714 Method for treating elevated intraocular pressure, including glaucoma |
| 08/05/2004 | US20040151710 Topical composition for treating infectious conditions of skin and mucosa |
| 08/05/2004 | US20040151673 Nonaerosol/aerosol dispensing of sunscreen sprays comprising silica microparticles |
| 08/05/2004 | US20040151671 Topical applying; pressurized container with alcohol foaming agents; acne therapy |
| 08/05/2004 | US20040150690 Medicament ejector with ejection port servicing |
| 08/05/2004 | DE20220910U1 Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden Compositions to prevent the misuse of opioids |
| 08/05/2004 | DE10354862A1 Solid pharmaceutical compositions containing ramipril, useful for treating hypertension, heart failure or nephropathy, having low water content to improve stability |
| 08/05/2004 | DE10304403A1 Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung A method for preparing an oral dosage form with immediate disintegration and drug release |
| 08/05/2004 | DE10302688A1 Kreide-Paraffin-Packungen Chalk paraffin wraps |